Nobuyoshi Fukushima - Concepedia

Author

Nobuyoshi Fukushima

Kurume University

Also Known As

Hiroshi Yatsuhashi, Makoto Nakamuta, Nobuyoshi FUKUSHIMA, Nobuyoshi Fukushima, Tetsuo Yamamoto

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Kurume University Kyushu University National Kyushu Medical Center Fukuoka University Nagasaki University

About

Nobuyoshi Fukushima is an author at Kurume University specializing in medicine, hepatology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	723
2	Hepatology	3	3	670
3	Public Health	1	1	53
4	Epidemiology	1	1	53
5	Immunology	1	1	17

Nobuyoshi Fukushima

Publications

983

Citations

H-Index

Page 1

	Year	Citations
Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors Shuji Sumie, Ryoko Kuromatsu, Koji Okuda, Annals of Surgical Oncology AngiogenesisHepatologyMedicineSurgical PathologyHistopathology	2008	384
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population Minoru Nakamura, Nao Nishida, Minae Kawashima, The American Journal of Human Genetics Genome-wide Association StudyHepatologyLiver PhysiologyGeneticsGenetic Epidemiology	2012	269
Genome-wide association studies identify<i>PRKCB</i>as a novel genetic susceptibility locus for primary biliary cholangitis in the Japanese population Minae Kawashima, Yuki Hitomi, Yoshihiro Aiba, Human Molecular Genetics GeneticsGenetic EpidemiologyPathologyDisease Gene IdentificationGenomics	2016	53
Surveillance Program for Early Detection of Hepatocellular Carcinoma in Japan Eiji Ando, Ryoko Kuromatsu, Masatoshi Tanaka, Journal of Clinical Gastroenterology	2006	49
Serum albumin level is a notable profiling factor for non‐<scp>B</scp>, non‐<scp>C</scp> hepatitis virus‐related hepatocellular carcinoma: A data‐mining analysis Shingo Yamada, Atsushi Kawaguchi, Takumi Kawaguchi, Hepatology Research	2013	35
Phosphorylated <scp>S</scp>mad2 and <scp>S</scp>mad3 signaling: Shifting between tumor suppression and fibro‐carcinogenesis in chronic hepatitis <scp>C</scp> Takashi Yamaguchi, Koichi Matsuzaki, Ryosuke Inokuchi, Hepatology Research	2013	28
Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection Shuji Sumie, Takumi Kawaguchi, Mina Komuta, Oncology Reports	2007	27
<scp>CD</scp>34<sup>+</sup> cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis Tõru Nakamura, Takuji Torimura, Hideki Iwamoto, Journal of Gastroenterology and Hepatology	2014	24
The incidence of hepatocellular carcinoma associated with hepatitis C infection decreased in Kyushu area Naota Taura, Nobuyoshi Fukushima, Hiroshi Yastuhashi, Medical Science Monitor	2011	22
Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C Nobuyoshi Fukushima, Ryoko Kuromatsu, Teruko Arinaga‐Hino, Hepatology Research	2010	19

Page 1